u/micro_bump_mick

a COA is a certificate of analysis, the lab document for a batch

Correction: that marker is reported in different units by different labs, which explains the tenfold difference you are seeing.

Careful — the supplier does not control the last mile and most of your variance is in it.

Not convinced by four data points. That is not a lane yet, it is an anecdote with a route attached.

reproducibility beats resolution if you only get one of them

Yes. Repeat before you react. Almost every alarming single value I have posted here regressed on the repeat.

reproducibility beats resolution if you only get one of them

Not convinced. You changed the dose and the week at the same time, so you cannot attribute the change to either.

Why the first fortnight tells you nothing.

With a week-long half-life, exposure declines over several weeks after a final dose rather than ending with it. So the first two weeks after stopping are still a tail of the previous state, and the stability people report in that window is not evidence about the months after it.

The reports here are fairly consistent: appetite noticeably different somewhere in the second month, weight following later, and the trajectory strongly influenced by whether the habits from the losing phase survived. That is not a prediction for anybody in particular, and it is not a schedule — it is the shape of what members describe, which is the most this board can honestly offer.

Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.

ApoB is the one worth adding if you only add one

sema is weekly for a reason, the half-life does the smoothing

stopping abruptly and stopping gradually are different experiences

The mental model that finally made this click for me: there are two curves, and people watch the wrong one.

The first is exposure, which is set by the dose and smoothed by a week-long half-life. It changes when you change the dose and then settles over about a month. The second is body weight, which is exposure filtered through appetite, food, water, sleep, training and the scale itself, and which moves in steps rather than a line.

Almost every "it stopped working" post is somebody watching curve two over a fortnight and drawing conclusions about curve one. If the appetite effect is still there, exposure is fine. Wait the month.

Did you run a blank between injections?

Same injection day each week, or has it drifted?

Not convinced by four data points. That is not a lane yet, it is an anecdote with a route attached.

This. A quoted lead time that holds is worth more than a fast one that does not.

assay method matters, especially between different labs

My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.

I would push back gently. Going up because the scale paused is the single most common mistake described on this board.

Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.

ApoB is the one worth adding if you only add one

Repeat testing before acting is standard practice for a reason: regression to the mean does a lot of work on single outlying values.

draw at the same point in the week if you want comparability

That result is preclinical. Worth flagging, since the thread has been reading it as human data.

Agreed that the vocabulary here is imprecise and it causes people to answer different questions to the ones asked.

read the wiki first, then ask anyway

the median is more useful than the fastest anybody ever got

no tracking numbers, ever

Small correction, said kindly: those are two different products with similar names, and the difference matters for a multi-draw vial.

two identical orders a week apart is the cheapest experiment available

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.

The appetite thing was the surprise. I expected to feel full. What I got was simply not thinking about food between meals.

Does early fullness track the day after the shot, or is it there all week?

Correct, and worth adding: the trial average is an average. Half the people in it did worse than 15% and were still on the drug.

Draw at the same point in the week now, fasting, same lab. The noise dropped enormously once I standardised.

Compared two draws across two labs and spent a week worrying before finding out the assays were different.

Right, and symptom patterns tracking the cycle rather than the dose explains a lot of confusing weeks.

Have you had the conversation with a clinician yet?